Centeon
Executive Summary
Company expects to restart production of "medically necessary" products in its Kankakee, Ill. facility in late October following reply to FDA. Centeon and the agency are discussing which products are "medically necessary." FDA ordered the company to halt production because of GMP violations ("The Pink Sheet" Sept. 14, p. 21)